Therapeutics and Clinical Risk Management | Volume 12 - Dove Press
Therapeutics and Clinical Risk Management | Volume 14 - Dove Press
Home Page: Journal of Allergy and Clinical Immunology
Therapeutics and Clinical Risk Management | Volume 14 - Dove Press
Therapeutics and Clinical Risk Management | Volume 14 - Dove Press
Impact of a five-dimensional framework on R&D productivity at AstraZeneca | Nature Reviews Drug Discovery
Therapeutics and Clinical Risk Management | Journal metrics - Dove Press
Therapeutics and Clinical Risk Management - Dove Press
Therapeutics and Clinical Risk Management - Dove Press
Therapeutics and Clinical Risk Management | Volume 14 - Dove Press
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases | Nature Reviews Drug Discovery
Therapeutics and Clinical Risk Management | Volume 11 - Dove Press
IJERPH | Announcements
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global
Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 - The Lancet
Risk Management for the 21st Century: Current Status and Future Needs | SpringerLink
Frontiers | Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies | Medicine
Editor's Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) - European Journal of Vascular and Endovascular Surgery
Therapeutics and Clinical Risk Management | Volume 14 - Dove Press
Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review - ScienceDirect
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study - ScienceDirect
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary | European Respiratory Society
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations - Annals of Oncology
Therapeutics and Clinical Risk Management | Volume 14 - Dove Press
Therapeutics and Clinical Risk Management – ScienceOpen
Therapeutics and Clinical Risk Management
